2633 — Jacobson Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Annual balance sheet for Jacobson Pharma, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	479	1,036	412	509	370
Net Total Accounts Receivable
Net Total Receivables	334	301	188	157	195
Total Inventory
Total Other Current Assets
Total Current Assets	1,178	1,757	964	1,038	986
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,504	1,502	1,301	1,494	1,508
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	4,756	5,380	3,487	3,645	3,564
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	826	656	373	553	717
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	2,264	2,644	1,115	1,192	1,248
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	2,491	2,737	2,372	2,453	2,316
Total Liabilities & Shareholders' Equity	4,756	5,380	3,487	3,645	3,564
Total Common Shares Outstanding